• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Unity Biotechnology Inc (NQ: UBX )

    1.470 -0.040 (-2.65%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 40,070
    Open 1.520
    Bid (Size) 1.460 (11)
    Ask (Size) 1.510 (15)
    Prev. Close 1.510
    Today's Range 1.460 - 1.520
    52wk Range 1.220 - 3.190
    Shares Outstanding 14,601,258
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    UBX Stock Earnings: Unity Biotechnology Beats EPS for Q1 2024
    UBX stock results show that Unity Biotechnology beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates
    From Unity Biotechnology, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -23.44%
    -23.44%
    1 Month
    +13.08%
    +13.08%
    3 Month
    -2.65%
    -2.65%
    6 Month
    -14.53%
    -14.53%
    1 Year
    -53.33%
    -53.33%

    More News

    Read More
    UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting
    From Unity Biotechnology, Inc.
    Via GlobeNewswire
    UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME
    From Unity Biotechnology, Inc.
    Via GlobeNewswire
    Analyst Ratings for Unity Biotechnology
    Via Benzinga
    The Latest Analyst Ratings for Unity Biotechnology
    Via Benzinga
    Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
    Via Benzinga
    UBX Stock Earnings: Unity Biotechnology Beats EPS for Q4 2023
    Via InvestorPlace
    UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
    From Unity Biotechnology, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Where Unity Biotechnology Stands With Analysts
    Via Benzinga
    Recap: Unity Biotechnology Q1 Earnings
    Via Benzinga
    New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss
    From Unity Biotechnology, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    UNITY Biotechnology Doses First Patients in Phase 2 ASPIRE Study of UBX1325 in DME
    From Unity Biotechnology, Inc.
    Via GlobeNewswire
    Unity Biotechnology Upgraded - Analyst Highlights Cash Strength & Execution
    Via Benzinga
    UNITY Biotechnology, Inc. Reports Third Quarter 2023 Financial Results and Business Updates
    From Unity Biotechnology, Inc.
    Via GlobeNewswire
    UNITY Biotechnology Announces Exercise of Warrants for $4.38 Million in Gross Proceeds
    From Unity Biotechnology, Inc.
    Via GlobeNewswire
    Are Longevity Stocks the Next Trillion-Dollar Industry? 3 Anti-Aging Picks
    Via InvestorPlace
    UNITY Biotechnology Announces 48-Week Results from Phase 2 ENVISION Study of UBX1325 in Patients with Wet Age-Related Macular Degeneration
    From Unity Biotechnology, Inc.
    Via GlobeNewswire
    UNITY Biotechnology, Inc. Reports Second Quarter 2023 Financial Results and Business Updates
    From Unity Biotechnology, Inc.
    Via GlobeNewswire
    Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023
    Via Benzinga
    UNITY Announces Design of Phase 2b ASPIRE Study Evaluating UBX1325 in Diabetic Macular Edema (DME)
    From Unity Biotechnology, Inc.
    Via GlobeNewswire
    Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2023
    Via Benzinga
    UNITY Biotechnology, Inc. Reports First Quarter 2023 Financial Results and Business Updates
    From Unity Biotechnology, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.